Lisata Therapeutics, Inc.
LSTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $25 | $22 | $13 | $46 |
| - Cash | $16 | $23 | $32 | $25 |
| + Debt | $0 | $0 | $0 | $1 |
| Enterprise Value | $9 | -$0 | -$19 | $23 |
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $1 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$22 | -$26 | -$58 | -$29 |
| % Margin | -2,223.5% | – | – | – |
| Net Income | -$20 | -$21 | -$54 | -$27 |
| % Margin | -1,998.5% | – | – | – |
| EPS Diluted | -2.4 | -2.58 | -10.47 | -7.45 |
| % Growth | 7% | 75.4% | -40.5% | – |
| Operating Cash Flow | -$19 | -$20 | -$21 | -$22 |
| Capital Expenditures | $0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$19 | -$20 | -$21 | -$22 |